These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
404 related items for PubMed ID: 19018048
1. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Keren R, Carpenter MA, Hoberman A, Shaikh N, Matoo TK, Chesney RW, Matthews R, Gerson AC, Greenfield SP, Fivush B, McLurie GA, Rushton HG, Canning D, Nelson CP, Greenbaum L, Bukowski T, Primack W, Sutherland R, Hosking J, Stewart D, Elder J, Moxey-Mims M, Nyberg L. Pediatrics; 2008 Dec; 122 Suppl 5(Suppl 5):S240-50. PubMed ID: 19018048 [Abstract] [Full Text] [Related]
2. Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Chesney RW, Carpenter MA, Moxey-Mims M, Nyberg L, Greenfield SP, Hoberman A, Keren R, Matthews R, Matoo TK, members of the RIVUR Steering Committee. Pediatrics; 2008 Dec; 122 Suppl 5(0 5):S233-9. PubMed ID: 19018047 [Abstract] [Full Text] [Related]
4. Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Mattoo TK, Chesney RW, Greenfield SP, Hoberman A, Keren R, Mathews R, Gravens-Mueller L, Ivanova A, Carpenter MA, Moxey-Mims M, Majd M, Ziessman HA, RIVUR Trial Investigators. Clin J Am Soc Nephrol; 2016 Jan 07; 11(1):54-61. PubMed ID: 26555605 [Abstract] [Full Text] [Related]
5. The role of antimicrobial prophylaxis in the management of children with vesicoureteral reflux--the RIVUR study outcomes. Mathews R, Mattoo TK. Adv Chronic Kidney Dis; 2015 Jul 07; 22(4):325-30. PubMed ID: 26088078 [Abstract] [Full Text] [Related]
6. Antimicrobial prophylaxis for children with vesicoureteral reflux. RIVUR Trial Investigators, Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, Pohl HG, Kropp BP, Skoog SJ, Nelson CP, Moxey-Mims M, Chesney RW, Carpenter MA. N Engl J Med; 2014 Jun 19; 370(25):2367-76. PubMed ID: 24795142 [Abstract] [Full Text] [Related]
9. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pennesi M, Travan L, Peratoner L, Bordugo A, Cattaneo A, Ronfani L, Minisini S, Ventura A, North East Italy Prophylaxis in VUR study group. Pediatrics; 2008 Jun 19; 121(6):e1489-94. PubMed ID: 18490378 [Abstract] [Full Text] [Related]
10. Vesicoureteral reflux and continuous prophylactic antibiotics. Lee T, Park JM. Investig Clin Urol; 2017 Jun 19; 58(Suppl 1):S32-S37. PubMed ID: 28612058 [Abstract] [Full Text] [Related]
11. Targeted Workup after Initial Febrile Urinary Tract Infection: Using a Novel Machine Learning Model to Identify Children Most Likely to Benefit from Voiding Cystourethrogram. Advanced Analytics Group of Pediatric Urology and ORC Personalized Medicine GroupDepartment of Urology, Boston Children's Hospital , Boston , Massachusetts.Operations Research Center, Massachusetts Institute of Technology , Cambridge , Massachusetts.. J Urol; 2019 Jul 19; 202(1):144-152. PubMed ID: 30810465 [Abstract] [Full Text] [Related]
12. Imaging studies after a first febrile urinary tract infection in young children. Hoberman A, Charron M, Hickey RW, Baskin M, Kearney DH, Wald ER. N Engl J Med; 2003 Jan 16; 348(3):195-202. PubMed ID: 12529459 [Abstract] [Full Text] [Related]
13. Changes in Clinical Presentation and Renal Outcomes among Children with Febrile Urinary Tract Infection: 2005 vs 2015. Lee T, Varda BK, Venna A, McCarthy I, Logvinenko T, Nelson CP. J Urol; 2021 Jun 16; 205(6):1764-1769. PubMed ID: 33535798 [Abstract] [Full Text] [Related]
14. A Reanalysis of the RIVUR Trial Using a Risk Classification System. Wang ZT, Wehbi E, Alam Y, Khoury A. J Urol; 2018 Jun 16; 199(6):1608-1614. PubMed ID: 29198997 [Abstract] [Full Text] [Related]
15. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L. Pediatrics; 2006 Mar 16; 117(3):626-32. PubMed ID: 16510640 [Abstract] [Full Text] [Related]
16. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Cheng CH, Tsai MH, Huang YC, Su LH, Tsau YK, Lin CJ, Chiu CH, Lin TY. Pediatrics; 2008 Dec 16; 122(6):1212-7. PubMed ID: 19047236 [Abstract] [Full Text] [Related]
17. Are clinical, laboratory, and imaging markers suitable predictors of vesicoureteral reflux in children with their first febrile urinary tract infection? Mahyar A, Ayazi P, Mavadati S, Oveisi S, Habibi M, Esmaeily S. Korean J Urol; 2014 Aug 16; 55(8):536-41. PubMed ID: 25132949 [Abstract] [Full Text] [Related]
18. Association of vesicoureteral reflux and renal scarring in urinary tract infections. Yılmaz İ, Peru H, Yılmaz FH, Sekmenli T, Çiftçi İ, Kara F. Arch Argent Pediatr; 2018 Aug 01; 116(4):e542-e547. PubMed ID: 30016028 [Abstract] [Full Text] [Related]
19. The RIVUR trial: a factual interpretation of our data. Mattoo TK, Carpenter MA, Moxey-Mims M, Chesney RW, RIVUR Trial Investigators. Pediatr Nephrol; 2015 May 01; 30(5):707-12. PubMed ID: 25558811 [Abstract] [Full Text] [Related]
20. Antibiotic prophylaxis for prevention of febrile urinary tract infections in children with vesicoureteral reflux: a meta-analysis of randomized, controlled trials comparing dilated to nondilated vesicoureteral reflux. de Bessa J, de Carvalho Mrad FC, Mendes EF, Bessa MC, Paschoalin VP, Tiraboschi RB, Sammour ZM, Gomes CM, Braga LH, Bastos Netto JM. J Urol; 2015 May 01; 193(5 Suppl):1772-7. PubMed ID: 25817142 [Abstract] [Full Text] [Related] Page: [Next] [New Search]